« Return to News | Study Conduct

AAHRPP Changes Process, Awards Fewer Accreditations

Monday, December 28, 2009 08:30 AM

Organizations accredited by the Accreditation of Human Research Protection Programs (AAHRPP) will soon be able to go longer between accreditation renewals as part of a number of process changes effective January 1.  

AAHRPP extended the time period between reaccreditations from three years to five while the period between initial accreditation and reaccreditation remains at three years.  The organization also revised its reporting procedure to request more specific information about changes and catastrophic events.  In addition, AAHRPP’s Council on Accreditation may now request status reports and conduct limited site visits to organizations to verify standards-compliance efforts.

AAHRPP accredits organizations that conduct or review research with humans. The non-profit accredited six organizations at the end of 2009, bringing the total number of AAHRPP clients to 200. Forty-one organizations were accredited in 2009, down from 67 in 2008.

The list of organizations that received full accreditation in December includes: Spectrum Health, Grand Rapids, Mich.; South Shore Hospital, South Weymouth, Mass.; HealthPartners Research Foundation, Minneapolis, Minn., The University of North Carolina at Chapel Hill, Chapel Hill, N.C., Independent Investigational Review Board, Plantation, Fla.; and Liberty IRB, DeLand, Fla.

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.